Combining patient-derived ex vivo carboplatin screening with bulk and single-cell transcriptomics, functional perturbation in cancer-associated fibroblasts, and high-resolution spatial transcriptomics, scientists identified stromal apolipoprotein L4 (APOL4) as a biomarker of platinum sensitivity.
[Experimental & Molecular Medicine]